News

Sunovion Pharmaceuticals Inc. (Sunovion) announced that results of a pivotal Phase 2/3 study (SEP360-202) evaluating novel drug candidate dasotraline in children ages 6 to 12 years with…
Read More...

Shionogi & Co., Ltd. has announced that cefiderocol (S-649266), a novel siderophore cephalosporin in late-stage development, met the FDA pre-specified primary endpoint for…
Read More...

Harrington Discovery Institute at University Hospitals in Cleveland, Ohio and the Alzheimer's Drug Discovery Foundation (ADDF) have expanded their collaboration to accelerate…
Read More...

Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, announced the expansion of its pipeline through the acquisition of a majority stake in TyrNovo Ltd., a…
Read More...

Pharma major Lupin said that it has launched in the US market its generic version of morphine sulfate ER tablets used for management of severe pain. The company said it has launched…
Read More...

Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) has issued a patent entitled "Compositions…
Read More...

Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited announced that they have entered a collaboration to develop Maverick’s T-cell…
Read More...

Valeant Pharmaceuticals International, Inc. announced that its affiliate has entered into a definitive agreement to sell all of the outstanding equity interests in Dendreon…
Read More...

ViraCyte, LLC announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Viralym-C, ViraCyte's T cell immunotherapy product designed to treat…
Read More...

Hutchison China MediTech Limited announces that it has initiated a Phase I trial of its novel spleen tyrosine kinase (“Syk”) inhibitor, HMPL-523, in patients with hematological…
Read More...

Emergent Technologies, Inc. (ETI) announced that its target discovery portfolio company, Pure MHC, and global biopharmaceutical company, AbbVie (NYSE:ABBV), will embark on a research…
Read More...

Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals, Inc. announced that they have entered into a definitive agreement under which Takeda will acquire all of the outstanding…
Read More...

Zebra Biologics Inc., an emerging pre-clinical stage biotechnology company, announced that the company has entered into a collaboration with AbbVie to discover agonist antibody…
Read More...

Ipsen announced that it has entered into a definitive agreement to acquire global oncology assets from Merrimack Pharmaceuticals, including its key marketed product ONIVYDE® (irinotecan…
Read More...

Enzyvant, a biopharmaceutical company focused on developing innovative treatments for patients with rare diseases, today announced entering into an exclusive worldwide licensing…
Read More...

Mast Therapeutics, Inc. and Savara Inc., a privately-held emerging specialty pharmaceutical company focused on the treatment of rare respiratory diseases, today announced that the two…
Read More...

San Diego based Ambrx Inc. and Suzhou based MabSpace Biosciences have agreed to collaborate on discovery and development of multiple novel ADCs in China and around the world for…
Read More...

Takeda Pharmaceutical Company Limited and PvP Biologics, Inc. announced a global agreement for the development of KumaMax, a novel enzyme designed to break down the immune-reactive…
Read More...

PTC Therapeutics, Inc. announced that its joint development program in Spinal Muscular Atrophy (SMA) with Roche and the SMA Foundation (SMAF) initiated a clinical study in infants with…
Read More...

Custopharm, Inc., a U.S. leader in generic injectable products, announced that it has acquired two paragraph IV abbreviated new drug application (ANDA) products from Perrigo Company…
Read More...